Sibutramine produces dose-related weight loss

Obesity Research

Volumn 7, Issue 2, 1999, Pages 189-198

  Bray, George A ^a   Blackburn, George L ^b   Ferguson, James M ^c   Greenway, Frank L ^a   Jain, Adesh K ^d   Mendel, Carl M ^e   Mendels, Joseph ^f   Ryan, Donna H ^a   Schwartz, Shenvyn L ^g   Scheinbaum, Monte L ^d   Seaton, Timothy B ^e  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Pharmacology Research Corporation   (United States)

^d General Clinical Research Center New Orleans   (United States)

^e ABBOTT LABORATORIES   (United States)

^f Philadelphia Medical Institute   (United States)

^g Diabetes and Glandular Disease Clinic   (United States)

Author keywords

Clinical trial; Lipids; Obesity

Indexed keywords

ANOREXIGENIC AGENT; CHOLESTEROL; CYCLOBUTANE DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIBUTRAMINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; WEIGHT REDUCTION;

ADULT; APPETITE DEPRESSANTS; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYCLOBUTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PLACEBOS; RISK FACTORS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 0033090465     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1550-8528.1999.tb00701.x     Document Type: Article

References (5)

1. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994;272:205-11.
2. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol. 1995;141:1128-41.
3. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes. 1992;16:397-415.
4. Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel. Ann Intern Med. 1993; 119:764-70.
5. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32.